Genome Medicine (Jan 2023)

Single-cell transcriptomics reveals a mechanosensitive injury signaling pathway in early diabetic nephropathy

  • Shuya Liu,
  • Yu Zhao,
  • Shun Lu,
  • Tianran Zhang,
  • Maja T. Lindenmeyer,
  • Viji Nair,
  • Sydney E. Gies,
  • Guochao Wu,
  • Robert G. Nelson,
  • Jan Czogalla,
  • Hande Aypek,
  • Stephanie Zielinski,
  • Zhouning Liao,
  • Melanie Schaper,
  • Damian Fermin,
  • Clemens D. Cohen,
  • Denis Delic,
  • Christian F. Krebs,
  • Florian Grahammer,
  • Thorsten Wiech,
  • Matthias Kretzler,
  • Catherine Meyer-Schwesinger,
  • Stefan Bonn,
  • Tobias B. Huber

DOI
https://doi.org/10.1186/s13073-022-01145-4
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 19

Abstract

Read online

Abstract Background Diabetic nephropathy (DN) is the leading cause of end-stage renal disease, and histopathologic glomerular lesions are among the earliest structural alterations of DN. However, the signaling pathways that initiate these glomerular alterations are incompletely understood. Methods To delineate the cellular and molecular basis for DN initiation, we performed single-cell and bulk RNA sequencing of renal cells from type 2 diabetes mice (BTBR ob/ob) at the early stage of DN. Results Analysis of differentially expressed genes revealed glucose-independent responses in glomerular cell types. The gene regulatory network upstream of glomerular cell programs suggested the activation of mechanosensitive transcriptional pathway MRTF-SRF predominantly taking place in mesangial cells. Importantly, activation of MRTF-SRF transcriptional pathway was also identified in DN glomeruli in independent patient cohort datasets. Furthermore, ex vivo kidney perfusion suggested that the regulation of MRTF-SRF is a common mechanism in response to glomerular hyperfiltration. Conclusions Overall, our study presents a comprehensive single-cell transcriptomic landscape of early DN, highlighting mechanosensitive signaling pathways as novel targets of diabetic glomerulopathy.